CVRx, Inc. - Common Stock, $0.01 par value (CVRX) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2021 to Q4 2025

Type / Class
Equity / Common Stock, $0.01 par value
Symbol
CVRX on Nasdaq
Shares outstanding
26,135,461
Price per share
$7.10
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
14,003,450
Total reported value
$113,001,810
% of total 13F portfolios
0%
Share change
-564,718
Value change
-$4,140,662
Number of holders
91
Price from insider filings
$7.10
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of CVRx, Inc. - Common Stock, $0.01 par value (CVRX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
JOHNSON & JOHNSON 15% $28,578,928 4,024,861 JOHNSON & JOHNSON 31 Dec 2025
NEW ENTERPRISE ASSOCIATES 10 L P 7.8% $13,635,539 2,026,083 New Enterprise Associates 10, Limited Partnership 18 Feb 2025
Vensana Capital I GP, LLC 7.2% $11,849,740 1,760,734 Kirk Nielsen 31 Dec 2024
Cooperatieve Gilde Healthcare IV U.A. 4.9% $8,287,928 1,231,490 Cooperatieve Gilde Healthcare IV U.A. 04 Feb 2025

As of 30 Sep 2025, 91 institutional investors reported holding 14,003,450 shares of CVRx, Inc. - Common Stock, $0.01 par value (CVRX). This represents 54% of the company’s total 26,135,461 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of CVRx, Inc. - Common Stock, $0.01 par value (CVRX) together control 50% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
JOHNSON & JOHNSON 16% 4,103,430 0% 6.6% $33,114,680
NEA Management Company, LLC 7.8% 2,026,083 0% 0.9% $16,350,490
VANGUARD GROUP INC 4.2% 1,090,226 +1.2% 0% $8,798,123
BlackRock, Inc. 3.9% 1,015,688 -1% 0% $8,196,602
Balyasny Asset Management L.P. 2.7% 696,260 +3.2% 0.01% $5,618,818
Parkman Healthcare Partners LLC 1.9% 491,408 -38% 0.44% $3,965,663
MORGAN STANLEY 1.7% 431,551 +17% 0% $3,482,617
GEODE CAPITAL MANAGEMENT, LLC 1.5% 404,955 +5.9% 0% $3,268,510
SILVERCREST ASSET MANAGEMENT GROUP LLC 1.4% 359,376 -2.8% 0.02% $2,900,164
STATE STREET CORP 1.1% 295,391 +0.22% 0% $2,383,805
MILLENNIUM MANAGEMENT LLC 0.87% 226,719 -30% 0% $1,829,622
GSA CAPITAL PARTNERS LLP 0.84% 220,446 -16% 0.15% $1,779,000
GOLDMAN SACHS GROUP INC 0.77% 202,057 +153% 0% $1,630,600
BANK OF AMERICA CORP /DE/ 0.69% 180,425 +103% 0% $1,456,030
UBS Group AG 0.58% 151,323 +72% 0% $1,221,177
NORTHERN TRUST CORP 0.57% 149,284 +0.61% 0% $1,204,722
FourWorld Capital Management LLC 0.55% 145,000 +17% 2.8% $1,170,150
MAIRS & POWER INC 0.55% 144,956 +0.47% 0.01% $1,169,795
Archon Capital Management LLC 0.55% 143,968 -18% 0.69% $1,161,822
TUDOR INVESTMENT CORP ET AL 0.48% 126,060 -18% 0.01% $1,017,304
D. E. Shaw & Co., Inc. 0.29% 76,449 +43% 0% $616,943
Cresset Asset Management, LLC 0.27% 71,802 +41% 0% $579,442
JANE STREET GROUP, LLC 0.27% 71,506 0% $577,054
Nuveen, LLC 0.26% 69,249 +64% 0% $558,839
Quantinno Capital Management LP 0.26% 67,057 +257% 0% $541,150

Institutional Holders of CVRx, Inc. - Common Stock, $0.01 par value (CVRX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 2,418 $17,168 +$1,200 $7.10 4
2025 Q3 14,003,450 $113,001,810 -$4,140,662 $8.07 91
2025 Q2 14,566,804 $85,403,778 -$19,986,146 $5.88 91
2025 Q1 15,971,769 $195,337,855 +$10,778,190 $12.23 95
2024 Q4 15,154,273 $192,128,165 +$11,666,171 $12.67 91
2024 Q3 14,208,138 $125,172,924 +$5,810,039 $8.81 84
2024 Q2 13,192,379 $158,176,281 -$11,196,197 $11.99 72
2024 Q1 13,441,680 $244,665,057 +$21,036,083 $18.21 87
2023 Q4 12,015,323 $377,446,209 +$6,898,602 $31.44 83
2023 Q3 11,953,961 $181,343,253 +$2,863,854 $15.17 64
2023 Q2 11,594,427 $179,048,989 +$23,946,250 $15.44 66
2023 Q1 10,400,213 $96,928,042 -$20,701,454 $9.32 61
2022 Q4 10,299,118 $188,989,468 +$3,540,115 $18.35 48
2022 Q3 10,529,611 $98,240,851 -$6,931,505 $9.33 37
2022 Q2 10,888,954 $65,444,210 -$7,076,705 $6.01 34
2022 Q1 12,073,187 $72,317,176 -$14,166,594 $5.99 55
2021 Q4 12,884,491 $157,579,777 -$25,347,085 $12.23 53
2021 Q3 11,758,612 $194,426,346 -$15,245,912 $16.54 49
2021 Q2 13,787,189 $386,044,000 +$386,044,000 $28.00 59